Inbenta Names Mark Leibowitz Chief Revenue Officer

According to Inbenta's press release on GlobeNewswire, Inbenta announced Mark Leibowitz as Chief Revenue Officer on April 30, 2026. The release states Leibowitz "will lead global revenue strategy, scale enterprise sales, and drive expansion" as Inbenta pushes into agentic AI deployments that autonomously resolve complex customer interactions end-to-end.

The release introduces Encore, described as Inbenta's next-generation AI platform combining AI orchestration, Live Agent Assist, and an AI-powered CX toolkit. Per the release, Encore uses a proprietary "Glass Box" knowledge-first architecture and attributes the following performance claims to the product: +98% accuracy, 75% faster deployment, and a 50% reduction in overhead. The release frames these capabilities as relevant for regulated industries where governance and auditability are required. The release also cites market context, stating North America accounted for 37.2% of global AI-for-customer-service revenue in 2024 and referencing a Forrester projection that 30% of enterprises will build parallel AI functions to support service operations this year.

The release summarizes Leibowitz's more than two decades of sales leadership in AI and SaaS, listing recent roles at Lyzr AI (Senior Director, BFSI Enterprise Sales), Yellow.ai (VP and Global Head, BFSI and Healthcare Sales), and prior senior sales leadership at Kore.ai, with client references such as SelectQuote and Assurant. The release includes a direct quote from Melissa Solis, CEO, Inbenta: "Mark's ability to build lasting enterprise relationships and deliver results in competitive markets is exactly what Inbenta needs as we bring Encore to market. His deep BFSI expertise, in an industry where governance, compliance, and accuracy are non-negotiable, makes him the ideal leader to show enterprises why CX AI is finally solved."

Industry-context observation: Vendors marketing CX AI for regulated sectors commonly emphasize governance, auditability, and reduced hallucinations to win enterprise procurement decisions. Companies attempting to scale into BFSI and healthcare often combine product claims about accuracy and deployment velocity with dedicated enterprise-sales hires to address procurement and risk teams.

Editorial analysis: Observers evaluating vendor claims should request third-party validation of accuracy and deployment metrics, and technical details on governance features (audit logs, explainability, data lineage). Enterprise buyers will likely probe integrations with existing case-management and contact-center systems, and measure end-to-end latency and failure modes in agentic workflows.

Watch for customer case studies and independent benchmarks that corroborate Encore's performance claims, and for commercial announcements showing traction in BFSI and healthcare verticals. Reporting will also be useful on how Inbenta operationalizes governance features in live, agentic deployments.